Exane Derivatives’s Danaher DHR Stock Holding History

Exane Derivatives’s Portfolio DHR Stock Details DHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.92M	Sell	8,551 -1,108	-11%	-$255K	1.1%	17
2022 Q1	$2.51M	Buy	9,659 +1,325	+16%	+$332K	0.71%	22
2021 Q4	$2.43M	Buy	8,334 +65	+0.8%	+$17.9K	0.59%	29
2021 Q3	$2.23M	Sell	8,269 -912	-10%	-$248K	0.54%	33
2021 Q2	$2.25M	Sell	9,181 -357	-4%	-$79.2K	0.51%	34
2021 Q1	$1.9M	Sell	9,538 -3,029	-24%	-$615K	0.54%	38
2020 Q4	$2.47M	Sell	12,567 -5,957	-32%	-$1.19M	0.73%	28
2020 Q3	$3.54M	Buy	18,524 +547	+3%	+$97.3K	1.02%	24
2020 Q2	$2.82M	Buy	17,977 +931	+5%	+$134K	0.75%	34
2020 Q1	$2.09M	Buy	17,046 +2,361	+16%	+$318K	0.58%	42
2019 Q4	$2.09M	Buy	14,685 +5,206	+55%	+$658K	0.39%	82
2019 Q3	$1.21M	Buy	9,479 +259	+3%	+$32.4K	0.22%	89
2019 Q2	$1.17M	Buy	9,220 +411	+5%	+$48.7K	0.2%	98
2019 Q1	$1.03M	Buy	8,809 +7,635	+650%	+$783K	0.2%	112
2018 Q4	$107K	Hold	1,174	–	–	0.02%	314
2018 Q3	$113K	Sell	1,174 -52	-4%	-$4.74K	0.02%	305
2018 Q2	$108K	Sell	1,226 -82	-6%	-$7.31K	0.02%	322
2018 Q1	$113K	Sell	1,308 -96	-7%	-$8.4K	0.02%	287
2017 Q4	$116K	Sell	1,404 -68	-5%	-$5.53K	0.02%	280
2017 Q3	$112K	Sell	1,472 -2	-0.1%	-$148	0.02%	243
2017 Q2	$110K	Sell	1,474 -9,574	-87%	-$717K	0.02%	264
2017 Q1	$838K	Buy	+11,048	New	+$822K	0.19%	95
2015 Q1	–	Sell	-2,614	Closed	-$151K	–	529
2014 Q4	$151K	Buy	+2,614	New	+$142K	0.02%	247

Other funds holding DHR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Exane Derivatives's DHR Position: Q2 2022 in Review

Exane Derivatives reduced its Danaher (DHR) stake by 11% in Q2 2022, selling an estimated $255K and leaving 8,551 shares worth $1.92M. The position accounts for 1.1% of the portfolio, ranked #17.

Exane Derivatives first reported a position in DHR in Q4 2014 and has held it in 23 quarters since. The position peaked at $3.54M in Q3 2020. 2,010 funds tracked by Wall St. Rank hold DHR as of Q2 2022.

Exane Derivatives held 8,551 shares of Danaher worth $1.92M as of Q2 2022.
Exane Derivatives sold 1,108 Danaher shares in Q2 2022, an estimated $255K.
Danaher made up 1.1% of Exane Derivatives's portfolio in Q2 2022, its #17 holding.
Exane Derivatives first reported a position in Danaher in Q4 2014 and has held it in 23 quarters since.
Exane Derivatives's Danaher position peaked at $3.54M in Q3 2020.
2,010 funds tracked by Wall St. Rank held Danaher as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.